Trials / Completed
CompletedNCT00131768
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study is to evaluate the safety and efficacy of Synvisc in patients with symptomatic ankle osteoarthritis (OA). Patients will be given Synvisc, with the possible administration of a second injection where insufficient symptomatic pain relief was experienced during the initial 3 months follow up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Synvisc (hylan G-F 20) |
Timeline
- Start date
- 2003-11-01
- Completion
- 2006-02-01
- First posted
- 2005-08-19
- Last updated
- 2015-03-18
Locations
5 sites across 3 countries: Germany, Italy, Netherlands
Source: ClinicalTrials.gov record NCT00131768. Inclusion in this directory is not an endorsement.